OMKAR SPECIALITY CHEMICALS LTD.

Omkar Speciality Chemicals Limited announced board changes following a meeting on October 15, 2026. Ms. Muskaan Pherwani resigned as an Additional Non-Executive Independent Director, effective October 13, 2026. The board accepted her resignation and noted there were no other material reasons. Concurrently, Ms. Shashi Kala Dhabriya was appointed as an Additional Non-Executive Independent Director for a term of five years, commencing October 15, 2026, subject to shareholder approval. Ms. Dhabriya, a homemaker with a Master of Arts degree, is not related to any other director or key managerial personnel.

Omkar Speciality Chemicals Limited announced in a Board Meeting held on October 15, 2026, the acceptance of Ms. Muskaan Pherwani's resignation as an Additional Director (Non-Executive Independent) effective October 13, 2026. Concurrently, the Board approved the appointment of Ms. Shashi Kala Dhabriya as an Additional Director in the category of Non-Executive Independent Director for a term of five years, commencing October 15, 2026, subject to member approval. Ms. Dhabriya, a homemaker with a Master of Arts in History, is not related to any existing directors or KMPs and is not debarred from holding directorships.

Omkar Speciality Chemicals Ltd has received approval from the Registrar of Companies, Maharashtra, Navi Mumbai, for a three-month extension to hold its Annual General Meeting (AGM). The approval, granted under Section 96 of the Companies Act, 2013, allows the company to conduct its AGM for the financial year ended March 31, 2026, on or before December 31, 2026. The company had applied for this extension due to reasons cited in its application, and the Registrar has advised future compliance with the Act.

Omkar Speciality Chemicals Ltd announced its unaudited financial results for the first quarter ended June 30, 2026. The Board of Directors approved the results along with the Limited Review report in a meeting held on August 14, 2026. The company reported a loss of ₹36.07 Lakhs for the quarter, compared to a loss of ₹40.98 Lakhs in the corresponding previous year quarter. No revenue was generated from operations during the quarter. The financial results have been prepared on a going concern basis, following the implementation of a Resolution Plan approved by the NCLT.

Omkar Speciality Chemicals Ltd has announced that its Board of Directors will convene on August 14, 2026. The primary agenda item is to consider and approve the Unaudited Financial Results for the quarter ended June 30, 2026. The company also noted that trading in its securities has been suspended effective April 29, 2026, following the implementation of a Resolution Plan.

Omkar Speciality Chemicals Ltd announced that its Board of Directors has approved the standalone audited financial statements for the quarter and financial year ended March 31, 2026. The board also approved the constitution of a Nomination and Remuneration Committee and a change in the registered office address. The financial statements were audited by RR. TIBREWALA & CO. The auditor's report notes that the company's financial statements have been prepared on a going concern basis and reflect the impact of a Resolution Plan approved by the NCLT.

Omkar Speciality Chemicals Limited has filed its unaudited financial statements for the quarters ending September 2022, December 2022, and audited financial statements for the years ended March 31, 2023, 2024, and 2025. The company was admitted into Corporate Insolvency Resolution Process (CIRP) by the NCLT, Mumbai Bench on December 5, 2022, which led to constraints preventing timely submission of previous quarterly reports. The board meeting held on August 7, 2026, approved these financial statements, which are now available on the company's website. The filings include standalone unaudited and audited financial results for the pending periods and independent auditor's reports.

Omkar Speciality Chemicals Ltd has scheduled a Board of Directors meeting for August 7, 2026, to approve financial statements for multiple past periods, including FY23, FY24, and FY25. The company explains that due to its Corporate Insolvency Resolution Process (CIRP), it was unable to submit financial results from FY2022 to FY2025. Reasons cited include resignation of Key Managerial Personnel, non-availability of records, and operational constraints. Trading in the company's equity shares remains suspended on BSE and NSE.

Omkar Speciality Chemicals Ltd announced that its Board of Directors, in a meeting held on June 25, 2026, has approved the sale of two properties located in the MIDC Industrial Area, Badlapur, District Thane. The specific properties include Plot No. W 83 (880 Sq. Mtrs.) and Plot No. W 93 (720 Sq. Mtrs.). The board has authorized directors to undertake necessary actions for these transactions. The company will continue to update the stock exchange on further developments as per regulatory requirements.

Omkar Speciality Chemicals Limited announced its audited standalone financial results for the quarter and financial year ended March 31, 2026. The Board of Directors also approved the formation of a Nomination and Remuneration Committee and a change in the registered office address. The company's financial statements were prepared on a going concern basis, with attention drawn to a Resolution Plan approved via an order dated July 31, 2025, which has been given effect in the financial statements. The auditor's report confirmed that the financial statements provide a true and fair view, though it highlighted the impact of the Resolution Plan and the going concern basis.